Vitamin D‐binding protein (group‐specific component) is the sole serum protein required for macrophage activation after treatment of peritoneal cells with lysophosphatidylcholine
- 1 August 1993
- journal article
- Published by Wiley in Immunology & Cell Biology
- Vol. 71 (4) , 249-257
- https://doi.org/10.1038/icb.1993.29
Abstract
In vitro treatment of mouse peritoneal cells with 1 g lysophosphatidylcholine (lyso–Pc)/mL in serum free-0.1% egg albumin-supplemented RPMI 1640 medium for 30 min, followed by 3 h cultivation in a medium supplemented with human serum, resulted in a greatly enhanced Fc-receptor-mediated phagocytic activity of macrophages. Vitamin D-binding protein (group-specific component [Gc]) of 2-globulin fraction was shown to he the sole serum glycoprotein required for the generation of a potent macrophage-activating factor. When a mixture of lysophosphatidylcholine (lyso-Pc)-treated nonadherent and adherent cells were cultured in a medium supplemented with a small amount of purified Gc protein (1 ng/mL), a greatly enhanced activation of macrophages was demonstrated. The generation of macrophage-activating factor from purified Gc protein was far more efficient than that from whole serum, indicating that a serum component is inhibitory to the activation process of macrophages. While three other major serum glycoproteins (2-macrcglobulin, 2-HS-glycoprotein and haptoglobin) were neither stimulatory nor inhibitory to lyso-Pc-primed macrophage activation, serum albumin (competitively with Gc protein) appeared to be inhibitory to the process of macrophage activation.Keywords
This publication has 14 references indexed in Scilit:
- Vitamin D3 binding protein (group-specific component) is a precursor for the macrophage-activating signal factor from lysophosphatidylcholine-treated lymphocytes.Proceedings of the National Academy of Sciences, 1991
- Mapping and conservation of the group-specific component gene in mouseGenomics, 1990
- A serum factor for macrophage activation after in vitro dodecylglycerol treatment of mouse lymphocytesImmunology & Cell Biology, 1990
- Contribution of Lysophosphatidylcholine-Treated Nonadherent Cells to Mechanism of Macrophage ActivationExperimental Biology and Medicine, 1990
- Activation process of macrophages afterin vitrotreatment of mouse lymphocytes with dodecylglycerolClinical and Experimental Immunology, 1990
- Specific uptake of alpha‐fetoprotein by malignant human lymphoid cellsInternational Journal of Cancer, 1987
- Effects of inflammation products on immune systemsCancer Immunology, Immunotherapy, 1986
- Human group-specific component (Gc) is a member of the albumin family.Proceedings of the National Academy of Sciences, 1985
- Activation of peritoneal macrophages by lysophosphatidylcholineBiochimica et Biophysica Acta (BBA) - General Subjects, 1985
- Studies of the macrophage complement receptor. Alteration of receptor function upon macrophage activation.The Journal of Experimental Medicine, 1975